Embryonic Stem Cells, Cardiomyoplasty, and the Risk of Teratoma Formation

[1]  J. Platt,et al.  Immunosuppression by Embryonic Stem Cells , 2008, Stem cells.

[2]  Ahmad Y. Sheikh,et al.  Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation. , 2007, Stem cells and development.

[3]  Marius Wernig,et al.  Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin , 2007, Science.

[4]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[5]  R. Crystal,et al.  Ablation of tumor-derived stem cells transplanted to the central nervous system by genetic modification of embryonic stem cells with a suicide gene. , 2007, Human gene therapy.

[6]  Guy Salama,et al.  Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia , 2007, Nature.

[7]  Ahmad Y. Sheikh,et al.  Molecular imaging of embryonic stem cell misbehavior and suicide gene ablation. , 2007, Cloning and stem cells.

[8]  R. Zweigerdt.  The art of cobbling a running pump--will human embryonic stem cells mend broken hearts? , 2007, Seminars in cell & developmental biology.

[9]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[10]  Rafael Beyar,et al.  Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. , 2007, Journal of the American College of Cardiology.

[11]  Chris Denning,et al.  Transgenic enrichment of cardiomyocytes from human embryonic stem cells. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  D. Pei,et al.  Direct generation of ES-like cells from unmodified mouse embryonic fibroblasts by Oct4/Sox2/Myc/Klf4 , 2007, Cell Research.

[13]  R. Kloner,et al.  Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. , 2007, Journal of molecular and cellular cardiology.

[14]  Ahmad Y. Sheikh,et al.  Differentiation, Survival, and Function of Embryonic Stem Cell–Derived Endothelial Cells for Ischemic Heart Disease , 2007, Circulation.

[15]  Lila R Collins,et al.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.

[16]  A. Hagège,et al.  Differentiation In Vivo of Cardiac Committed Human Embryonic Stem Cells in Postmyocardial Infarcted Rats , 2007, Stem cells.

[17]  Marius Wernig,et al.  Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells , 2007, Nature Biotechnology.

[18]  S. E. Jacobsen,et al.  Potential risks of bone marrow cell transplantation into infarcted hearts. , 2007, Blood.

[19]  N. Benvenisty,et al.  Clonal Analysis of Human Embryonic Stem Cell Differentiation into Teratomas , 2007, Stem cells.

[20]  L. Gepstein,et al.  Identification and selection of cardiomyocytes during human embryonic stem cell differentiation , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  G. Lyons,et al.  Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. , 2007, American journal of physiology. Heart and circulatory physiology.

[22]  R. Jaenisch,et al.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state , 2007, Nature.

[23]  T. Ichisaka,et al.  Generation of germline-competent induced pluripotent stem cells , 2007, Nature.

[24]  S. Gerecht,et al.  Human embryonic stem cell transplantation to repair the infarcted myocardium , 2007, Heart.

[25]  J. Utikal,et al.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. , 2007, Cell stem cell.

[26]  C. Ware,et al.  The FASEB Journal • Research Communication , 2007 .

[27]  Patrick Delafontaine,et al.  Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. , 2007, Biochemical and biophysical research communications.

[28]  B. Fleischmann,et al.  Serpin-6 Expression Protects Embryonic Stem Cells from Lysis by Antigen-Specific CTL1 , 2007, The Journal of Immunology.

[29]  D. K. Arrell,et al.  Cardiopoietic programming of embryonic stem cells for tumor-free heart repair , 2007, The Journal of experimental medicine.

[30]  A. Hagège,et al.  Is xenotransplantation of embryonic stem cells a realistic option? , 2007, Transplantation.

[31]  Jifeng Zhang,et al.  Transplantation of human undifferentiated embryonic stem cells into a myocardial infarction rat model. , 2007, Stem cells and development.

[32]  J. Hare,et al.  Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche , 2007, Nature Clinical Practice Cardiovascular Medicine.

[33]  M. Ashraf,et al.  In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. , 2007, Journal of molecular and cellular cardiology.

[34]  M. Molcanyi,et al.  Embryonic stem cell transplantation after experimental traumatic brain injury dramatically improves neurological outcome, but may cause tumors. , 2007, Journal of neurotrauma.

[35]  Arjun Deb,et al.  Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  J. Odorico,et al.  Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression. , 2006, Stem cells and development.

[37]  Chunhui Xu,et al.  Cardiac bodies: a novel culture method for enrichment of cardiomyocytes derived from human embryonic stem cells. , 2006, Stem cells and development.

[38]  N. Zavazava,et al.  Immunogenicity and Engraftment of Mouse Embryonic Stem Cells in Allogeneic Recipients , 2006, Stem cells.

[39]  J. Platt,et al.  Complement-Dependent Control of Teratoma Formation by Embryonic Stem Cells1 , 2006, The Journal of Immunology.

[40]  Ralf Kettenhofen,et al.  Engraftment of engineered ES cell–derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium , 2006, The Journal of experimental medicine.

[41]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[42]  Rudolf Jaenisch,et al.  Nuclear reprogramming and pluripotency , 2006, Nature.

[43]  S. V. Anisimov,et al.  Transplantation of Human Embryonic Stem Cell‐Derived Cells to a Rat Model of Parkinson's Disease: Effect of In Vitro Differentiation on Graft Survival and Teratoma Formation , 2006, Stem cells.

[44]  M. Stojkovic,et al.  Growth of teratomas derived from human pluripotent stem cells is influenced by the graft site. , 2006, Stem cells and development.

[45]  D. Solter,et al.  From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research , 2006, Nature Reviews Genetics.

[46]  Sanjiv S. Gambhir,et al.  In Vivo Visualization of Embryonic Stem Cell Survival, Proliferation, and Migration After Cardiac Delivery , 2006, Circulation.

[47]  P. Wolf,et al.  Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2006, Circulation.

[48]  N. Benvenisty,et al.  Human Embryonic Stem Cells and Their Differentiated Derivatives Are Less Susceptible to Immune Rejection Than Adult Cells , 2006, Stem cells.

[49]  S. Dymarkowski,et al.  Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial , 2006, The Lancet.

[50]  P. Menasché,et al.  Cell-based cardiac repair: reflections at the 10-year point. , 2005, Circulation.

[51]  S. Przyborski.  Differentiation of Human Embryonic Stem Cells After Transplantation in Immune‐Deficient Mice , 2005, Stem cells.

[52]  Emmanuel Messas,et al.  Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study , 2005, The Lancet.

[53]  Chunhui Xu,et al.  Formation of human myocardium in the rat heart from human embryonic stem cells. , 2005, The American journal of pathology.

[54]  I. Weissman,et al.  They are not stealthy in the heart: embryonic stem cells trigger cell infiltration, humoral and T-lymphocyte-based host immune response. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[55]  H. Vogel,et al.  Embryonic Stem Cell Immunogenicity Increases Upon Differentiation After Transplantation Into Ischemic Myocardium , 2005, Circulation.

[56]  C. Murry,et al.  Regenerating the heart , 2005, Nature Biotechnology.

[57]  Megan Sykes,et al.  Organ transplantation—how much of the promise has been realized? , 2005, Nature Medicine.

[58]  I. Weissman,et al.  Stimulation of Paracrine Pathways With Growth Factors Enhances Embryonic Stem Cell Engraftment and Host-Specific Differentiation in the Heart After Ischemic Myocardial Injury , 2005, Circulation.

[59]  N. Zavazava,et al.  Induction of Stable Mixed Chimerism by Embryonic Stem Cells Requires Functional Fas/FasL Engagement , 2005, Transplantation.

[60]  E. Shezen,et al.  Embryonic pig liver, pancreas, and lung as a source for transplantation: optimal organogenesis without teratoma depends on distinct time windows. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[61]  I. Weissman,et al.  Insulin‐Like Growth Factor Promotes Engraftment, Differentiation, and Functional Improvement after Transfer of Embryonic Stem Cells for Myocardial Restoration , 2004, Stem cells.

[62]  M. Wendel,et al.  Organized development from human embryonic stem cells after injection into immunodeficient mice. , 2004, Stem cells and development.

[63]  A. Terzic,et al.  Stable benefit of embryonic stem cell therapy in myocardial infarction. , 2004, American journal of physiology. Heart and circulatory physiology.

[64]  Bernd Hertenstein,et al.  Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial , 2004, The Lancet.

[65]  Li Li,et al.  Human Embryonic Stem Cells Possess Immune‐Privileged Properties , 2004, Stem cells.

[66]  O. Yanuka,et al.  Differentiation and isolation of hepatic-like cells from human embryonic stem cells. , 2004, Differentiation; research in biological diversity.

[67]  B. Lawrenz,et al.  Highly sensitive biosafety model for stem-cell-derived grafts. , 2004, Cytotherapy.

[68]  B. Fleischmann,et al.  Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation , 2004, Nature Medicine.

[69]  David A. Williams,et al.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts , 2004, Nature.

[70]  Patrick W Serruys,et al.  Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. , 2003, Journal of the American College of Cardiology.

[71]  Y. Bergman,et al.  Oct-3/4 is a dose-dependent oncogenic fate determinant. , 2003, Cancer cell.

[72]  M. Hoehn,et al.  Host-Dependent Tumorigenesis of Embryonic Stem Cell Transplantation in Experimental Stroke , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[73]  E. Audinat,et al.  Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[74]  M. Schuldiner,et al.  Selective Ablation of Human Embryonic Stem Cells Expressing a “Suicide” Gene , 2003, Stem cells.

[75]  Yong-Fu Xiao,et al.  Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. , 2003, The Journal of thoracic and cardiovascular surgery.

[76]  A. Terzic,et al.  Stem cell differentiation requires a paracrine pathway in the heart , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[77]  I. Zvibel,et al.  Anoikis: Roadblock to Cell Transplantation? , 2002, Cell transplantation.

[78]  Marius Wernig,et al.  Tau EGFP embryonic stem cells: An efficient tool for neuronal lineage selection and transplantation , 2002, Journal of neuroscience research.

[79]  Micha Drukker,et al.  Integration and differentiation of human embryonic stem cells transplanted to the chick embryo , 2002, Developmental dynamics : an official publication of the American Association of Anatomists.

[80]  Maya Schuldiner,et al.  Characterization of the expression of MHC proteins in human embryonic stem cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Naohiro Terada,et al.  Embryoid‐body cells derived from a mouse embryonic stem cell line show differentiation into functional hepatocytes , 2002, Hepatology.

[82]  P. Andrews,et al.  From teratocarcinomas to embryonic stem cells. , 2002, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[83]  C. Murry,et al.  Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. , 2002, Journal of molecular and cellular cardiology.

[84]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[85]  A M Wobus,et al.  Selection of ventricular‐like cardiomyocytes from ES cells in vitro , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[86]  I. Penn.  Post-Transplant Malignancy , 2000, Drug safety.

[87]  A. Trounson,et al.  Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro , 2000, Nature Biotechnology.

[88]  M. Schuldiner,et al.  Differentiation of Human Embryonic Stem Cells into Embryoid Bodies Comprising the Three Embryonic Germ Layers , 1999 .

[89]  J. Reig,et al.  Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. , 2000, Diabetes.

[90]  J. Mcdonald,et al.  Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord , 1999, Nature Medicine.

[91]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[92]  R. Lovell-Badge,et al.  Generation of purified neural precursors from embryonic stem cells by lineage selection , 1998, Current Biology.

[93]  G. Koh,et al.  Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. , 1996, The Journal of clinical investigation.

[94]  G. Martin,et al.  Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[95]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[96]  P. Avner,et al.  Isolation of a human teratoma cell line which expresses F9 antigen , 1977, Nature.

[97]  M. Evans,et al.  Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[98]  M. Evans,et al.  The morphology and growth of a pluripotent teratocarcinoma cell line and its derivatives in tissue culture. , 1974, Cell.

[99]  D. Solter,et al.  Extrauterine Growth of Mouse Egg-cylinders results in Malignant Teratoma , 1970, Nature.

[100]  B. Ephrussi,et al.  RETENTION OF MULTIPLE DEVELOPMENTAL POTENTIALITIES BY CELLS OF A MOUSE TESTICULAR TERATOCARCINOMA DURING PROLONGED CULTURE in vitro AND THEIR EXTINCTION UPON HYBRIDIZATION WITH CELLS OF PERMANENT LINES. , 1967, Proceedings of the National Academy of Sciences of the United States of America.

[101]  G. B. Pierce,et al.  MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS. , 1964, Cancer research.

[102]  L. C. Stevens.  EXPERIMENTAL PRODUCTION OF TESTICULAR TERATOMAS IN MICE. , 1964, Proceedings of the National Academy of Sciences of the United States of America.

[103]  L. C. Stevens,et al.  Spontaneous Testicular Teratomas in an Inbred Strain of Mice. , 1954, Proceedings of the National Academy of Sciences of the United States of America.

[104]  Takashi Aoi,et al.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts , 2008, Nature Biotechnology.

[105]  Dinender K. Singla,et al.  Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types. , 2006, Journal of molecular and cellular cardiology.

[106]  G. Dellgren,et al.  Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings. , 2006, Reproductive biomedicine online.

[107]  S. Arii,et al.  Teratoma formation and hepatocyte differentiation in mouse liver transplanted with mouse embryonic stem cell-derived embryoid bodies. , 2005, Transplantation proceedings.

[108]  A. Tanigami,et al.  Embryonic stem cells injected into the mouse knee joint form teratomas and subsequently destroy the joint. , 2003, Rheumatology.

[109]  N. Friedman,et al.  Human and porcine early kidney precursors as a new source for transplantation , 2003, Nature Medicine.

[110]  J. Fogh,et al.  New Human Tumor Cell Lines , 1975 .

[111]  J. Fogh.  Human Tumor Cells in Vitro , 1975, Springer US.